Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohortopen access
- Authors
- Parker, Ben; Urowitz, Murray B.; Gladman, Dafna D.; Lunt, Mark; Bae, Sang-Cheol; Sanchez-Guerrero, Jorge; Romero-Diaz, Juanita; Gordon, Caroline; Wallace, Daniel J.; Clarke, Ann E.; Bernatsky, Sasha; Ginzler, Ellen M.; Isenberg, David A.; Rahman, Anisur; Merrill, Joan T.; Alarcon, Graciela S.; Fessler, Barri J.; Fortin, Paul R.; Hanly, John G.; Petri, Michelle; Steinsson, Kristjan; Dooley, Mary-Anne; Manzi, Susan; Khamashta, Munther A.; Ramsey-Goldman, Rosalind; Zoma, Asad A.; Sturfelt, Gunnar K.; Nived, Ola; Aranow, Cynthia; Mackay, Meggan; Ramos-Casals, Manuel; van Vollenhoven, Raymond F.; Kalunian, Kenneth C.; Ruiz-Irastorza, Guillermo; Lim, Sam; Kamen, Diane L.; Peschken, Christine A.; Inanc, Murat; Bruce, Ian N.
- Issue Date
- Aug-2013
- Publisher
- BMJ PUBLISHING GROUP
- Keywords
- Systemic Lupus Erythematosus; Cardiovascular Disease; Inflammation; Epidemiology
- Citation
- ANNALS OF THE RHEUMATIC DISEASES, v.72, no.8, pp.1308 - 1314
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF THE RHEUMATIC DISEASES
- Volume
- 72
- Number
- 8
- Start Page
- 1308
- End Page
- 1314
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/26673
- DOI
- 10.1136/annrheumdis-2012-202106
- ISSN
- 0003-4967
- Abstract
- Background
The metabolic syndrome (MetS) may contribute to increased cardiovascular risk in systemic lupus erythematosus (SLE). We aimed to examine the association of demographic factors, lupus phenotype and therapy exposure with the presence of MetS.
Methods
The Systemic Lupus International Collaborating Clinics Registry for Atherosclerosis inception cohort enrolled recently diagnosed (<15 months) SLE patients from 30 centres across 11 countries from 2000. Clinical, laboratory and therapeutic data were collected according to a standardised protocol. MetS was defined according to the 2009 consensus statement from the International Diabetes Federation. Univariate and backward stepwise multivariate logistic regression were used to assess the relationship of individual variables with MetS.
Results
We studied 1686 patients, of whom 1494 (86.6%) had sufficient data to determine their MetS status. The mean (SD) age at enrolment and disease duration was 35.2 years (13.4) and 24.1 weeks (18.0), respectively. MetS was present at the enrolment visit in 239 (16%). In backward stepwise multivariable regression analysis, higher daily average prednisolone dose (mg) (OR 1.02, 95% CI 1.00 to 1.03), older age (years) (OR 1.04, 95% CI 1.03 to 1.06), Korean (OR 6.33, 95% CI 3.68 to 10.86) and Hispanic (OR 6.2, 95% CI 3.78 to 10.12) ethnicity, current renal disease (OR 1.79, 95% CI 1.14 to 2.80) and immunosuppressant use (OR 1.81, 95% CI 1.18 to 2.78) were associated with MetS.
Conclusions
Renal lupus, higher corticosteroid doses, Korean and Hispanic ethnicity are associated with MetS in SLE patients. Balancing disease control and minimising corticosteroid exposure should therefore be at the forefront of personalised treatment decisions in SLE patients.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/26673)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.